Skip to content

Early DETECTion of ColoRectal Cancer in Yorkshire (DETECT-CRC): Feasibility study assessing active case finding of colorectal cancer in socio-economically deprived areas.

‘Open-label’, cluster randomised controlled trial, randomly allocating pharmacies in lower super output areas (LSOAs) to compare active case-finding of bowel cancer versus usual care alone with an equal allocation ratio.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14156362
Enrollment
40
Registered
2024-04-02
Start date
2025-01-01
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colo-rectal cancer Cancer

Interventions

Open-label, parallel group, cluster randomised controlled feasibility trial, randomly allocating geographical areas defined by one or more adjacent lower super output areas (LSOAs) to compare active c

Sponsors

University of Sheffield
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Pharmacy inclusion criteria: 1. South Yorkshire pharmacies in LSOAs in Deciles 1 and 2 of the Index of Multiple Deprivation. 2. Willing to be randomised to active case finding or usual care. 3. Willing to distribute FIT kits to people attending pharmacy as per the details in protocol. 4. Have read the study-specific SOP and can follow all the elements laid out therein. 5. Have access to PharmOutcomes online system. 6. Have completed the required ACF training associated with the service. 7. Able to offer face to face consultations in a private room.

Exclusion criteria

Exclusion criteria: Pharmacy exclusion criteria: 1. Unable to meet the trial requirements for storing and distributing FIT kits

Design outcomes

Primary

MeasureTime frame
Feasibility of recruitment to main trial: Number of people who were given a FIT kit from pharmacies delivering the active case finding service (measured using screening log data collected by participating pharmacies) over 12 months.

Secondary

MeasureTime frame
1. Intervention adherence - defined objectively as the number of FIT samples performed after dissemination in pharmacy settings - (measured using a unique identifier to enable tracking when the test is received by the central lab) over 12 months. 2. Patients’ views on acceptability of research procedures and intervention measured using semi structured qualitative interviews after at least 3 months of ACF service being delivered. 3. Pharmacists’ views on intervention/research protocol acceptability measured using semi structured qualitative interviews after at least 3 months of ACF service being delivered. 4. General Practitioners’ views on intervention/research protocol acceptability measured using semi structured qualitative interviews after at least 3 months of ACF service being delivered. 5. Feasibility of recruiting community pharmacies - measured using field notes to record problems with project approvals and set-up at participating pharmacy sites; target sites for the main trial.

Countries

England, United Kingdom

Contacts

Public ContactNaseeb Ezaydi
n.ezaydi@sheffield.ac.uk+44 (0) 114 215 9426

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026